Your browser doesn't support javascript.
loading
Effects of astragaloside on TRPC6 expression on mouse podocyte induced by TGF-β1 / 中国免疫学杂志
Chinese Journal of Immunology ; (12): 370-373, 2017.
Artigo em Chinês | WPRIM | ID: wpr-510465
ABSTRACT

Objective:

To explore the possible mechanism of astragaloside involved in the mouse podocytes injury induced by TGF-β1 in vitro.

Methods:

Mouse podocytes were cultured in vitro and then all cell were divided into 5 groupsnormal control group , TGF-β1 treatment group ,TGF-β1 treatment +astragaloside low dose group ,TGF-β1 treatment +astragaloside middle dose group and TGF-β1 treatment +astragaloside high dose group.The proliferation rate of each group was investigated by MTT assay ,the expression of TRPC6 protein and mRNA were measured by Western blot and RT-PCR respectively after 48 hours.

Results:

TGF-β1 can significantly inhibit the proliferation of podocytes ( P<0.05) ,fusions of foot processes or even effaced of podocytes were observed .TGF-β1 could also increase the expression of TRPC6.Astragaloside could reduce the inhibition of TGF-β1 to the proliferain of podocytes significantly ,make the cell shape tend to be normal,and reduce the expression of TRPC6 mRNA and protein with dose-effect relation.

Conclusion:

TRPC6 play an impor-tant role in the TGF-β1 induecd podocytes injury .Astragaloside can alleviate podocytes injury by reduce the expression of TRPC 6.

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Immunology Ano de publicação: 2017 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: DisponíveL Índice: WPRIM (Pacífico Ocidental) Idioma: Chinês Revista: Chinese Journal of Immunology Ano de publicação: 2017 Tipo de documento: Artigo